FS Development
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FS Development and buy or sell other stocks, ETFs, and their options commission-free!About FSII
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease.
CEOJames B. Tananbaum, MD, MBA
CEOJames B. Tananbaum, MD, MBA
Employees—
Employees—
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2020
Founded2020
Employees—
Employees—
FSII Key Statistics
Market cap133.95M
Market cap133.95M
Price-Earnings ratio-1.36
Price-Earnings ratio-1.36
Dividend yield—
Dividend yield—
Average volume840.73K
Average volume840.73K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.41
52 Week high$3.41
52 Week low$0.75
52 Week low$0.75
Stock Snapshot
As of today, FS Development(FSII) shares are valued at $12.75. The company's market cap stands at 133.95M, with a P/E ratio of -1.36.
On 2025-11-05, FS Development(FSII) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for FS Development(FSII) stock has reached 0, versus its average volume of 840.73K.
The stock's 52-week range extends from a low of $0.75 to a high of $3.41.
The stock's 52-week range extends from a low of $0.75 to a high of $3.41.
People also own
Based on the portfolios of people who own FSII. This list is generated using Robinhood data, and it’s not a recommendation.